Clinical Trial Contact Request

An Expanded Access Program for the non-invasive detection of clear cell renal cell carcinoma in patients with renal masses utilizing 89Zirconium-labelled girentuximab (89Zr-DFO-girentuximab)

Please complete the form below to be contacted by our Clinical Trial Information Service
 (1024)
By submitting this form, you accept our Terms & Conditions and grant permission for us to contact you. We will not sell or share your information (Privacy Policy). Please do not submit another person’s name or email without his or her consent.
© 2021 Carebox. All rights reserved.